Logo image of IFX.DE

INFINEON TECHNOLOGIES AG (IFX.DE) Stock Fundamental Analysis

Europe - FRA:IFX - DE0006231004 - Common Stock

32.225 EUR
-0.42 (-1.3%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, IFX scores 4 out of 10 in our fundamental rating. IFX was compared to 56 industry peers in the Semiconductors & Semiconductor Equipment industry. There are concerns on the financial health of IFX while its profitability can be described as average. IFX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IFX had positive earnings in the past year.
IFX had a positive operating cash flow in the past year.
Each year in the past 5 years IFX has been profitable.
Each year in the past 5 years IFX had a positive operating cash flow.
IFX.DE Yearly Net Income VS EBIT VS OCF VS FCFIFX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

IFX has a worse Return On Assets (2.42%) than 75.00% of its industry peers.
IFX's Return On Equity of 4.06% is on the low side compared to the rest of the industry. IFX is outperformed by 73.21% of its industry peers.
IFX has a Return On Invested Capital of 5.54%. This is comparable to the rest of the industry: IFX outperforms 44.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IFX is below the industry average of 14.85%.
The 3 year average ROIC (11.24%) for IFX is well above the current ROIC(5.54%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.42%
ROE 4.06%
ROIC 5.54%
ROA(3y)7.79%
ROA(5y)5.95%
ROE(3y)13.34%
ROE(5y)10.66%
ROIC(3y)11.24%
ROIC(5y)8.52%
IFX.DE Yearly ROA, ROE, ROICIFX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IFX has a worse Profit Margin (4.63%) than 75.00% of its industry peers.
In the last couple of years the Profit Margin of IFX has declined.
IFX has a worse Operating Margin (10.54%) than 62.50% of its industry peers.
In the last couple of years the Operating Margin of IFX has grown nicely.
With a Gross Margin value of 39.84%, IFX is not doing good in the industry: 66.07% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IFX has grown nicely.
Industry RankSector Rank
OM 10.54%
PM (TTM) 4.63%
GM 39.84%
OM growth 3Y8.56%
OM growth 5Y3.29%
PM growth 3Y-6.29%
PM growth 5Y-4.73%
GM growth 3Y1.76%
GM growth 5Y1.71%
IFX.DE Yearly Profit, Operating, Gross MarginsIFX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IFX is still creating some value.
Compared to 1 year ago, IFX has less shares outstanding
IFX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IFX is higher compared to a year ago.
IFX.DE Yearly Shares OutstandingIFX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
IFX.DE Yearly Total Debt VS Total AssetsIFX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

IFX has an Altman-Z score of 3.48. This indicates that IFX is financially healthy and has little risk of bankruptcy at the moment.
IFX has a Altman-Z score of 3.48. This is in the lower half of the industry: IFX underperforms 64.29% of its industry peers.
The Debt to FCF ratio of IFX is 9.82, which is on the high side as it means it would take IFX, 9.82 years of fcf income to pay off all of its debts.
IFX has a Debt to FCF ratio of 9.82. This is in the lower half of the industry: IFX underperforms 67.86% of its industry peers.
IFX has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
IFX has a Debt to Equity ratio (0.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 9.82
Altman-Z 3.48
ROIC/WACC0.57
WACC9.75%
IFX.DE Yearly LT Debt VS Equity VS FCFIFX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.78 indicates that IFX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.78, IFX is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
IFX has a Quick Ratio of 1.78. This is a bad value and indicates that IFX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.99, IFX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.99
IFX.DE Yearly Current Assets VS Current LiabilitesIFX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for IFX have decreased strongly by -24.14% in the last year.
Measured over the past years, IFX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.75% on average per year.
Looking at the last year, IFX shows a decrease in Revenue. The Revenue has decreased by -3.61% in the last year.
IFX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.25% yearly.
EPS 1Y (TTM)-24.14%
EPS 3Y15.94%
EPS 5Y15.75%
EPS Q2Q%-13.95%
Revenue 1Y (TTM)-3.61%
Revenue growth 3Y10.58%
Revenue growth 5Y13.25%
Sales Q2Q%0.05%

3.2 Future

The Earnings Per Share is expected to grow by 13.46% on average over the next years. This is quite good.
Based on estimates for the next years, IFX will show a small growth in Revenue. The Revenue will grow by 7.42% on average per year.
EPS Next Y-20.2%
EPS Next 2Y1.15%
EPS Next 3Y9.35%
EPS Next 5Y13.46%
Revenue Next Year-1.95%
Revenue Next 2Y3.66%
Revenue Next 3Y6.05%
Revenue Next 5Y7.42%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IFX.DE Yearly Revenue VS EstimatesIFX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
IFX.DE Yearly EPS VS EstimatesIFX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.93 indicates a rather expensive valuation of IFX.
Compared to the rest of the industry, the Price/Earnings ratio of IFX indicates a somewhat cheap valuation: IFX is cheaper than 69.64% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of IFX to the average of the S&P500 Index (27.20), we can say IFX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.84, IFX is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IFX indicates a somewhat cheap valuation: IFX is cheaper than 67.86% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of IFX to the average of the S&P500 Index (22.71), we can say IFX is valued slightly cheaper.
Industry RankSector Rank
PE 20.93
Fwd PE 16.84
IFX.DE Price Earnings VS Forward Price EarningsIFX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IFX is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IFX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 76.93
EV/EBITDA 13.4
IFX.DE Per share dataIFX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.33
EPS Next 2Y1.15%
EPS Next 3Y9.35%

4

5. Dividend

5.1 Amount

IFX has a Yearly Dividend Yield of 1.10%.
Compared to an average industry Dividend Yield of 1.29, IFX pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.10, IFX pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

The dividend of IFX is nicely growing with an annual growth rate of 6.41%!
Dividend Growth(5Y)6.41%
Div Incr Years3
Div Non Decr Years4
IFX.DE Yearly Dividends per shareIFX.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

IFX pays out 67.11% of its income as dividend. This is not a sustainable payout ratio.
IFX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP67.11%
EPS Next 2Y1.15%
EPS Next 3Y9.35%
IFX.DE Yearly Income VS Free CF VS DividendIFX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
IFX.DE Dividend Payout.IFX.DE Dividend Payout, showing the Payout Ratio.IFX.DE Dividend Payout.PayoutRetained Earnings

INFINEON TECHNOLOGIES AG

FRA:IFX (9/16/2025, 7:00:00 PM)

32.225

-0.42 (-1.3%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-13 2025-11-13/amc
Inst Owners46.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap42.08B
Analysts83.23
Price Target42.91 (33.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Yearly Dividend0.35
Dividend Growth(5Y)6.41%
DP67.11%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.82%
Min EPS beat(2)3.19%
Max EPS beat(2)12.46%
EPS beat(4)4
Avg EPS beat(4)10.6%
Min EPS beat(4)2.81%
Max EPS beat(4)23.94%
EPS beat(8)8
Avg EPS beat(8)9.05%
EPS beat(12)12
Avg EPS beat(12)8.86%
EPS beat(16)16
Avg EPS beat(16)10.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.87%
Min Revenue beat(2)-1.02%
Max Revenue beat(2)-0.72%
Revenue beat(4)1
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)5.55%
Revenue beat(8)2
Avg Revenue beat(8)-0.74%
Revenue beat(12)4
Avg Revenue beat(12)-0.21%
Revenue beat(16)8
Avg Revenue beat(16)0.51%
PT rev (1m)2.54%
PT rev (3m)6.27%
EPS NQ rev (1m)3.8%
EPS NQ rev (3m)-17.84%
EPS NY rev (1m)-6.96%
EPS NY rev (3m)-6.96%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-6.74%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-2.22%
Valuation
Industry RankSector Rank
PE 20.93
Fwd PE 16.84
P/S 2.88
P/FCF 76.93
P/OCF 14.45
P/B 2.52
P/tB 5.5
EV/EBITDA 13.4
EPS(TTM)1.54
EY4.78%
EPS(NY)1.91
Fwd EY5.94%
FCF(TTM)0.42
FCFY1.3%
OCF(TTM)2.23
OCFY6.92%
SpS11.21
BVpS12.8
TBVpS5.85
PEG (NY)N/A
PEG (5Y)1.33
Profitability
Industry RankSector Rank
ROA 2.42%
ROE 4.06%
ROCE 6.82%
ROIC 5.54%
ROICexc 5.95%
ROICexgc 10.43%
OM 10.54%
PM (TTM) 4.63%
GM 39.84%
FCFM 3.74%
ROA(3y)7.79%
ROA(5y)5.95%
ROE(3y)13.34%
ROE(5y)10.66%
ROIC(3y)11.24%
ROIC(5y)8.52%
ROICexc(3y)13.19%
ROICexc(5y)10.13%
ROICexgc(3y)27.93%
ROICexgc(5y)22.61%
ROCE(3y)13.84%
ROCE(5y)10.48%
ROICexcg growth 3Y-5.66%
ROICexcg growth 5Y1.68%
ROICexc growth 3Y6.77%
ROICexc growth 5Y-4.81%
OM growth 3Y8.56%
OM growth 5Y3.29%
PM growth 3Y-6.29%
PM growth 5Y-4.73%
GM growth 3Y1.76%
GM growth 5Y1.71%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 9.82
Debt/EBITDA 1.23
Cap/Depr 124.13%
Cap/Sales 16.16%
Interest Coverage 250
Cash Conversion 84.46%
Profit Quality 80.68%
Current Ratio 1.78
Quick Ratio 0.99
Altman-Z 3.48
F-Score5
WACC9.75%
ROIC/WACC0.57
Cap/Depr(3y)151.77%
Cap/Depr(5y)128.29%
Cap/Sales(3y)17.6%
Cap/Sales(5y)15.83%
Profit Quality(3y)37.85%
Profit Quality(5y)92.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.14%
EPS 3Y15.94%
EPS 5Y15.75%
EPS Q2Q%-13.95%
EPS Next Y-20.2%
EPS Next 2Y1.15%
EPS Next 3Y9.35%
EPS Next 5Y13.46%
Revenue 1Y (TTM)-3.61%
Revenue growth 3Y10.58%
Revenue growth 5Y13.25%
Sales Q2Q%0.05%
Revenue Next Year-1.95%
Revenue Next 2Y3.66%
Revenue Next 3Y6.05%
Revenue Next 5Y7.42%
EBIT growth 1Y-42.72%
EBIT growth 3Y20.04%
EBIT growth 5Y16.98%
EBIT Next Year45.14%
EBIT Next 3Y32.02%
EBIT Next 5Y23.94%
FCF growth 1Y-49.4%
FCF growth 3Y-66.12%
FCF growth 5Y-16.47%
OCF growth 1Y-25%
OCF growth 3Y-3.2%
OCF growth 5Y11.67%